Smoking Cessation in Coronary Artery Disease

Magnitude of Risk with Continued Smoking

The European Society of Cardiology guidelines state that patients with established coronary artery disease who continue smoking face a 55% increased risk of death and more than double the risk of sudden cardiac death compared to those who quit 1, 2
Mortality risk increases by 55% in patients who continue smoking versus those who quit, with 5-year mortality rates of 22% for continued smokers versus 15% for quitters 2
Sudden cardiac death risk increases 2.5-fold in current smokers with CAD, representing one of the most powerful independent predictors of this outcome 2, 3
The 10-year fatal CVD risk is approximately doubled in smokers, with relative risk in 50-year-old smokers being five-fold higher than non-smokers 1, 4

The European Society of Cardiology guidelines emphasize that even modest and low levels of smoking confer vascular risk with a dose-response relationship showing no lower limit for deleterious effects 1, 4
All types of smoked tobacco are harmful, including low-tar cigarettes, filtered cigarettes, cigars, pipes, and water pipes 1, 4
Passive smoking increases CAD risk by an estimated 30%, making complete avoidance of smoke exposure essential 1, 4

Morbidity reductions occur within the first 6 months after quitting, with systematic reviews showing reductions in recurrent MIs and death/MI composite endpoints compared to continued smoking 1, 4
Cardiac death risk decreases by 37% within just 1 year of smoking cessation, with sustained benefit for those who quit for at least 3 years 2, 3
CVD risk approaches that of never-smokers within 10-15 years after quitting, though it never fully equals never-smoker risk 1, 4
Smoking cessation after CABG shows 10-year survival rates of 82% in quitters versus 77% in continued smokers, with lower rates of recurrent angina and repeat hospitalization 2, 3

The American College of Cardiology/American Heart Association provides guidance that tobacco use should be assessed at every health care visit to facilitate identification of patients who may benefit from intervention 6
Patients should be advised to quit at every visit, as this repeated advice increases cessation rates 6
Combination therapy is most effective: behavioral interventions combined with pharmacotherapy maximizes cessation rates 6, 7
Brief interventions plus drug therapy and follow-up support represent the most effective approach, with professional support increasing odds of stopping by 66% 7, 1

Underestimating the impact of "light" smoking: Even reduced smoking levels carry significant cardiovascular risk with no safe threshold 1, 4
Failing to address passive smoke exposure: Patients must avoid all secondhand smoke, as workplace or home exposure increases CVD risk by 30% 1, 6
Delaying cessation interventions: Evidence-based cessation treatments were underused, and 16% of CAD patients continued smoking 16 months after their coronary event 1, 8
Not combining pharmacological and behavioral approaches: Monotherapy is less effective than combination strategies for achieving sustained cessation 6